Cost of chronic inflammatory disease: The impact of eosinophilic esophagitis in Nevada
Objectives The cost of treating the rare eosinophilic esophagitis (EoE) disease and its impact on patients’ quality of life have not been well documented in the literature. This study seeks to fill this gap by comparing the cost of EoE with other well‐known inflammatory diseases, including Crohn...
Gespeichert in:
| Veröffentlicht in: | Journal of digestive diseases 2020-01, Vol.21 (1), p.12-19 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 19 |
|---|---|
| container_issue | 1 |
| container_start_page | 12 |
| container_title | Journal of digestive diseases |
| container_volume | 21 |
| creator | Anderson, Julia Moonie, Sheniz Hogan, Mary Beth Scherr, Rebecca Labus, Brian Word, Jessica |
| description | Objectives
The cost of treating the rare eosinophilic esophagitis (EoE) disease and its impact on patients’ quality of life have not been well documented in the literature. This study seeks to fill this gap by comparing the cost of EoE with other well‐known inflammatory diseases, including Crohn's disease (CD) and celiac disease (CeD).
Methods
A Mann‐Whitney U test and multiple logistic regression were used to examine the cost of EoE in the state of Nevada across all hospital settings and its impact on quality of life compared with CD and CeD.
Results
Several factors were associated with the overall cost of EoE in Nevada, including patients’ age, sex and region (P |
| doi_str_mv | 10.1111/1751-2980.12832 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2317600806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2317600806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3712-1f89e9fc8d3b74c42dc4570bd7609c78a5c46435ad2db535947d0227373cf6363</originalsourceid><addsrcrecordid>eNqFkDtPwzAUhS0EouUxs6FILCyhjh3bCRtKeUkVLIXVcmyHukriECeg_nucpnRg4S6-1_c7R_YB4CKCN5GvWcRIFKI08SNKMDoA0_3N4b5naAJOnFtDSChL6DGYYL8hNEZT8J5Z1wW2COSqtbWRgamLUlSV6Gy7CZRxWjh9GyxXOjBVI-SW1daZ2jYrU3qBdr4TH6YzzouDF_0llDgDR4UonT7fnafg7eF-mT2Fi9fH5-xuEUrMIhRGRZLqtJCJwjmLZYyUjAmDuWIUppIlgsiYxpgIhVROMEljpiBCDDMsC4opPgXXo2_T2s9eu45XxkldlqLWtncc-Z9SCBM4oFd_0LXt29q_zlOY0hQRmnpqNlKytc61uuBNayrRbngE-RA5H0LlQ8B8G7lXXO58-7zSas__ZuwBMgLfptSb__x4Np-Pxj_s54lO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2336692569</pqid></control><display><type>article</type><title>Cost of chronic inflammatory disease: The impact of eosinophilic esophagitis in Nevada</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Anderson, Julia ; Moonie, Sheniz ; Hogan, Mary Beth ; Scherr, Rebecca ; Labus, Brian ; Word, Jessica</creator><creatorcontrib>Anderson, Julia ; Moonie, Sheniz ; Hogan, Mary Beth ; Scherr, Rebecca ; Labus, Brian ; Word, Jessica</creatorcontrib><description>Objectives
The cost of treating the rare eosinophilic esophagitis (EoE) disease and its impact on patients’ quality of life have not been well documented in the literature. This study seeks to fill this gap by comparing the cost of EoE with other well‐known inflammatory diseases, including Crohn's disease (CD) and celiac disease (CeD).
Methods
A Mann‐Whitney U test and multiple logistic regression were used to examine the cost of EoE in the state of Nevada across all hospital settings and its impact on quality of life compared with CD and CeD.
Results
Several factors were associated with the overall cost of EoE in Nevada, including patients’ age, sex and region (P < 0.001). EoE was significantly more expensive to treat in the pediatric group ($4001 EoE; $985 CD; $856 CeD), among men ($2532 EoE; $1500 CD; $1724 CeD), among those residing in the southern region of Nevada ($4501 EoE; $2538 CD; $1888 CeD), and among patients seeking medical care from outpatient clinics ($3298 EoE; $741 CD; $1686 CeD) (P < 0.001). Age, sex, region and hospital setting were all associated with having a positive EoE record compared with CeD or CD (P < 0.001).
Conclusions
Data from this study indicate that the EoE burden is significantly higher in cost for certain demographics and regions compared with CD and CeD in the state of Nevada, specifically among pediatric and male patients. These differences suggest that clinicians may encounter similar issues when treating EoE.</description><identifier>ISSN: 1751-2972</identifier><identifier>EISSN: 1751-2980</identifier><identifier>DOI: 10.1111/1751-2980.12832</identifier><identifier>PMID: 31755642</identifier><language>eng</language><publisher>Melbourne: Wiley Publishing Asia Pty Ltd</publisher><subject>Autoimmune diseases ; Celiac disease ; chronic disease ; costs and cost analysis ; Crohn's disease ; Demography ; eosinophilic esophagitis ; epidemiology ; Esophageal diseases ; Esophagitis ; Esophagus ; Gastrointestinal diseases ; Inflammatory bowel diseases ; Inflammatory diseases ; Leukocytes (eosinophilic) ; logistic models ; Patients ; Pediatrics ; Quality of life</subject><ispartof>Journal of digestive diseases, 2020-01, Vol.21 (1), p.12-19</ispartof><rights>2020 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd</rights><rights>2020 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3712-1f89e9fc8d3b74c42dc4570bd7609c78a5c46435ad2db535947d0227373cf6363</citedby><cites>FETCH-LOGICAL-c3712-1f89e9fc8d3b74c42dc4570bd7609c78a5c46435ad2db535947d0227373cf6363</cites><orcidid>0000-0001-5582-7206</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1751-2980.12832$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1751-2980.12832$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31755642$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anderson, Julia</creatorcontrib><creatorcontrib>Moonie, Sheniz</creatorcontrib><creatorcontrib>Hogan, Mary Beth</creatorcontrib><creatorcontrib>Scherr, Rebecca</creatorcontrib><creatorcontrib>Labus, Brian</creatorcontrib><creatorcontrib>Word, Jessica</creatorcontrib><title>Cost of chronic inflammatory disease: The impact of eosinophilic esophagitis in Nevada</title><title>Journal of digestive diseases</title><addtitle>J Dig Dis</addtitle><description>Objectives
The cost of treating the rare eosinophilic esophagitis (EoE) disease and its impact on patients’ quality of life have not been well documented in the literature. This study seeks to fill this gap by comparing the cost of EoE with other well‐known inflammatory diseases, including Crohn's disease (CD) and celiac disease (CeD).
Methods
A Mann‐Whitney U test and multiple logistic regression were used to examine the cost of EoE in the state of Nevada across all hospital settings and its impact on quality of life compared with CD and CeD.
Results
Several factors were associated with the overall cost of EoE in Nevada, including patients’ age, sex and region (P < 0.001). EoE was significantly more expensive to treat in the pediatric group ($4001 EoE; $985 CD; $856 CeD), among men ($2532 EoE; $1500 CD; $1724 CeD), among those residing in the southern region of Nevada ($4501 EoE; $2538 CD; $1888 CeD), and among patients seeking medical care from outpatient clinics ($3298 EoE; $741 CD; $1686 CeD) (P < 0.001). Age, sex, region and hospital setting were all associated with having a positive EoE record compared with CeD or CD (P < 0.001).
Conclusions
Data from this study indicate that the EoE burden is significantly higher in cost for certain demographics and regions compared with CD and CeD in the state of Nevada, specifically among pediatric and male patients. These differences suggest that clinicians may encounter similar issues when treating EoE.</description><subject>Autoimmune diseases</subject><subject>Celiac disease</subject><subject>chronic disease</subject><subject>costs and cost analysis</subject><subject>Crohn's disease</subject><subject>Demography</subject><subject>eosinophilic esophagitis</subject><subject>epidemiology</subject><subject>Esophageal diseases</subject><subject>Esophagitis</subject><subject>Esophagus</subject><subject>Gastrointestinal diseases</subject><subject>Inflammatory bowel diseases</subject><subject>Inflammatory diseases</subject><subject>Leukocytes (eosinophilic)</subject><subject>logistic models</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Quality of life</subject><issn>1751-2972</issn><issn>1751-2980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkDtPwzAUhS0EouUxs6FILCyhjh3bCRtKeUkVLIXVcmyHukriECeg_nucpnRg4S6-1_c7R_YB4CKCN5GvWcRIFKI08SNKMDoA0_3N4b5naAJOnFtDSChL6DGYYL8hNEZT8J5Z1wW2COSqtbWRgamLUlSV6Gy7CZRxWjh9GyxXOjBVI-SW1daZ2jYrU3qBdr4TH6YzzouDF_0llDgDR4UonT7fnafg7eF-mT2Fi9fH5-xuEUrMIhRGRZLqtJCJwjmLZYyUjAmDuWIUppIlgsiYxpgIhVROMEljpiBCDDMsC4opPgXXo2_T2s9eu45XxkldlqLWtncc-Z9SCBM4oFd_0LXt29q_zlOY0hQRmnpqNlKytc61uuBNayrRbngE-RA5H0LlQ8B8G7lXXO58-7zSas__ZuwBMgLfptSb__x4Np-Pxj_s54lO</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Anderson, Julia</creator><creator>Moonie, Sheniz</creator><creator>Hogan, Mary Beth</creator><creator>Scherr, Rebecca</creator><creator>Labus, Brian</creator><creator>Word, Jessica</creator><general>Wiley Publishing Asia Pty Ltd</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5582-7206</orcidid></search><sort><creationdate>202001</creationdate><title>Cost of chronic inflammatory disease: The impact of eosinophilic esophagitis in Nevada</title><author>Anderson, Julia ; Moonie, Sheniz ; Hogan, Mary Beth ; Scherr, Rebecca ; Labus, Brian ; Word, Jessica</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3712-1f89e9fc8d3b74c42dc4570bd7609c78a5c46435ad2db535947d0227373cf6363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Autoimmune diseases</topic><topic>Celiac disease</topic><topic>chronic disease</topic><topic>costs and cost analysis</topic><topic>Crohn's disease</topic><topic>Demography</topic><topic>eosinophilic esophagitis</topic><topic>epidemiology</topic><topic>Esophageal diseases</topic><topic>Esophagitis</topic><topic>Esophagus</topic><topic>Gastrointestinal diseases</topic><topic>Inflammatory bowel diseases</topic><topic>Inflammatory diseases</topic><topic>Leukocytes (eosinophilic)</topic><topic>logistic models</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anderson, Julia</creatorcontrib><creatorcontrib>Moonie, Sheniz</creatorcontrib><creatorcontrib>Hogan, Mary Beth</creatorcontrib><creatorcontrib>Scherr, Rebecca</creatorcontrib><creatorcontrib>Labus, Brian</creatorcontrib><creatorcontrib>Word, Jessica</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of digestive diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anderson, Julia</au><au>Moonie, Sheniz</au><au>Hogan, Mary Beth</au><au>Scherr, Rebecca</au><au>Labus, Brian</au><au>Word, Jessica</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost of chronic inflammatory disease: The impact of eosinophilic esophagitis in Nevada</atitle><jtitle>Journal of digestive diseases</jtitle><addtitle>J Dig Dis</addtitle><date>2020-01</date><risdate>2020</risdate><volume>21</volume><issue>1</issue><spage>12</spage><epage>19</epage><pages>12-19</pages><issn>1751-2972</issn><eissn>1751-2980</eissn><abstract>Objectives
The cost of treating the rare eosinophilic esophagitis (EoE) disease and its impact on patients’ quality of life have not been well documented in the literature. This study seeks to fill this gap by comparing the cost of EoE with other well‐known inflammatory diseases, including Crohn's disease (CD) and celiac disease (CeD).
Methods
A Mann‐Whitney U test and multiple logistic regression were used to examine the cost of EoE in the state of Nevada across all hospital settings and its impact on quality of life compared with CD and CeD.
Results
Several factors were associated with the overall cost of EoE in Nevada, including patients’ age, sex and region (P < 0.001). EoE was significantly more expensive to treat in the pediatric group ($4001 EoE; $985 CD; $856 CeD), among men ($2532 EoE; $1500 CD; $1724 CeD), among those residing in the southern region of Nevada ($4501 EoE; $2538 CD; $1888 CeD), and among patients seeking medical care from outpatient clinics ($3298 EoE; $741 CD; $1686 CeD) (P < 0.001). Age, sex, region and hospital setting were all associated with having a positive EoE record compared with CeD or CD (P < 0.001).
Conclusions
Data from this study indicate that the EoE burden is significantly higher in cost for certain demographics and regions compared with CD and CeD in the state of Nevada, specifically among pediatric and male patients. These differences suggest that clinicians may encounter similar issues when treating EoE.</abstract><cop>Melbourne</cop><pub>Wiley Publishing Asia Pty Ltd</pub><pmid>31755642</pmid><doi>10.1111/1751-2980.12832</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5582-7206</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1751-2972 |
| ispartof | Journal of digestive diseases, 2020-01, Vol.21 (1), p.12-19 |
| issn | 1751-2972 1751-2980 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2317600806 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Autoimmune diseases Celiac disease chronic disease costs and cost analysis Crohn's disease Demography eosinophilic esophagitis epidemiology Esophageal diseases Esophagitis Esophagus Gastrointestinal diseases Inflammatory bowel diseases Inflammatory diseases Leukocytes (eosinophilic) logistic models Patients Pediatrics Quality of life |
| title | Cost of chronic inflammatory disease: The impact of eosinophilic esophagitis in Nevada |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T02%3A58%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost%20of%20chronic%20inflammatory%20disease:%20The%20impact%20of%20eosinophilic%20esophagitis%20in%20Nevada&rft.jtitle=Journal%20of%20digestive%20diseases&rft.au=Anderson,%20Julia&rft.date=2020-01&rft.volume=21&rft.issue=1&rft.spage=12&rft.epage=19&rft.pages=12-19&rft.issn=1751-2972&rft.eissn=1751-2980&rft_id=info:doi/10.1111/1751-2980.12832&rft_dat=%3Cproquest_cross%3E2317600806%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2336692569&rft_id=info:pmid/31755642&rfr_iscdi=true |